Nomura Asset Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-100
| Closed | -$2.3K | – | 1649 |
|
|
2023
Q4 | $2.3K | Hold |
100
| – | – | ﹤0.01% | 1524 |
|
|
2023
Q3 | $2.04K | Hold |
100
| – | – | ﹤0.01% | 1537 |
|
|
2023
Q2 | $2.34K | Hold |
100
| – | – | ﹤0.01% | 1546 |
|
|
2023
Q1 | $2.33K | Sell |
100
-22,700
| -100% | -$528K | ﹤0.01% | 1538 |
|
|
2022
Q4 | $574K | Hold |
22,800
| – | – | ﹤0.01% | 859 |
|
|
2022
Q3 | $602K | Buy |
22,800
+22,700
| +22,700% | +$599K | ﹤0.01% | 845 |
|
|
2022
Q2 | $1.5M | Hold |
100
| – | – | 0.01% | 757 |
|
|
2022
Q1 | $3.45K | Buy |
+100
| New | +$3.45K | ﹤0.01% | 1546 |
|
|
2021
Q4 | – | Sell |
-6,300
| Closed | -$319K | – | 1143 |
|
|
2021
Q3 | $319K | Hold |
6,300
| – | – | ﹤0.01% | 893 |
|
|
2021
Q2 | $328K | Hold |
6,300
| – | – | ﹤0.01% | 933 |
|
|
2021
Q1 | $288K | Buy |
+6,300
| New | +$288K | ﹤0.01% | 921 |
|